logo
ResearchBunny Logo
SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals

Medicine and Health

SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals

K. Sano, D. Bhavsar, et al.

This study reveals that mRNA vaccination generates stronger mucosal secretory IgA responses in individuals previously infected with SARS-CoV-2, enhancing their post-vaccination immunity. Conducted by a team of experts including Kaori Sano, Disha Bhavsar, and Viviana Simon, the findings are crucial in understanding vaccine efficacy in different populations.

00:00
00:00
~3 min • Beginner • English
Abstract
Immune responses at the respiratory mucosal interface are critical to prevent respiratory infections but it is unclear to what extent antigen specific mucosal secretory IgA (SIgA) antibodies are induced by mRNA vaccination in humans. Here we analyze paired serum and saliva samples from patients with and without prior coronavirus disease 2019 (COVID-19) at multiple time points pre and post severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccination. Our results suggest mucosal SIgA responses induced by mRNA vaccination are more robustly induced in individuals with pre-exposure to SARS-CoV-2 while SIgA induction after vaccination was more efficient in patients with a history of COVID-19.
Publisher
Nature Communications
Published On
Sep 01, 2022
Authors
Kaori Sano, Disha Bhavsar, Gagandeep Singh, Daniel Floda, Komal Srivastava, Charles Gleason, PARIS Study Group, Juan Manuel Carreño, Viviana Simon, Florian Krammer
Tags
mRNA vaccination
COVID-19
SARS-CoV-2
secretory IgA
immune response
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny